findmyKOL
Clinical trialNCT02628405UnknownPhase 1/PHASE2Interventional

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

SponsorAcademic and Community Cancer Research UnitedEnrollment30Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell LymphomaRecurrent Transformed Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • Carle Cancer Center Nci Community Oncology Research Program

    Urbana, Illinois, United States

  • University of Iowa/holden Comprehensive Cancer Center

    Iowa City, Iowa, United States

  • Siouxland Regional Cancer Center

    Sioux City, Iowa, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

  • Coborn Cancer Center at Saint Cloud Hospital

    Saint Cloud, Minnesota, United States

  • Metro Minnesota Community Oncology Research Consortium

    Saint Louis Park, Minnesota, United States

  • Dartmouth Hitchcock Medical Center/dartmouth Cancer Center

    Lebanon, New Hampshire, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • State University of New York Upstate Medical University

    Syracuse, New York, United States

  • Rapid City Regional Hospital

    Rapid City, South Dakota, United States

  • Marshfield Medical Center-Marshfield

    Marshfield, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 May 2016
Primary completion
24 Sept 2021
Completion
20 Dec 2025
Last update posted
1 Jul 2024
Registered enrollment
30
Registry id
NCT02628405
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.